Zeynab Najafova
Stuttgart, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
PHF19 drives the formation of PRC2 clusters to enhance motility in TNBC cells.
Journal: Cell reports
Published: April 06, 2025
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer.
Journal: Gut
Published: November 18, 2024
CRISPR GENome and epigenome engineering improves loss-of-function genetic-screening approaches.
Journal: Cell reports methods
Published: May 14, 2024
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.
Journal: Molecular cancer research : MCR
Published: November 14, 2022
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.
Journal: Cancers
Published: May 04, 2021
STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer.
Journal: Cancer research
Published: August 21, 2020
RNF40 exerts stage-dependent functions in differentiating osteoblasts and is essential for bone cell crosstalk.
Journal: Cell death and differentiation
Published: February 04, 2020
Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacities.
Journal: Acta physiologica (Oxford, England)
Published: November 07, 2018
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Journal: Clinical epigenetics
Published: August 28, 2018
Last Updated: 09/26/2026